The invention relates to a novel thiazolo[3,2-c]pyrimidine based anticancer compounds which may show effect on various cancer types (breast, liver, lung, colon, skin, prostate, kidney, ovarian, etc.)L'invention concerne de nouveaux composés anticancéreux à base de thiazolo [3,2-c]pyrimidine qui peuvent présenter un effet sur divers types de cancer (sein, foie, poumon, côlon, peau, prostate, rein, ovaire, etc.)